Literature DB >> 31266668

Chile's National Advisory Committee on Immunization (CAVEI): Evidence-based recommendations for public policy decision-making on vaccines and immunization.

Jeannette Dabanch1, Cecilia González2, Jaime Cerda3, Johanna Acevedo4, Mario Calvo5, Eduardo Díaz6, María Endeiza7, Jaime Inostroza8, Jaime Rodríguez9, Adiela Saldaña10, Solange Santillana11, Nathalie El Omeiri12, Magdalena Bastías13.   

Abstract

A National Immunization Technical Advisory Group (NITAG) provides independent, evidence-based recommendations to the Ministry of Health for immunization programmes and policy formulation. In this article, we describe the structure, functioning and work processes of Chile's NITAG (CAVEI) and assess its functionality, quality of work processes and outputs, and integration of the committee into the Ministry of Health policy process using the Assessment tool for National Immunization Technical Advisory Groups. Among its strengths, CAVEI's administrative and work plasticity allows it to respond in a timely manner to the Ministry of Health's requests and proactively raise subjects for review. Representation of multiple areas of expertise within the committee makes CAVEI a robust and balanced entity for the development of evidence-based comprehensive recommendations. High ranking profile of the Secretariat structure furthers CAVEI's competences in policymaking and serves as a bridge between the committee and international initiatives in the field of immunizations.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Keywords:  Chile; Evidence-based recommendations; Immunization decision-making; Immunization policy; National Immunization Technical Advisory Group

Year:  2019        PMID: 31266668     DOI: 10.1016/j.vaccine.2019.06.069

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  1 in total

1.  Moroccan National Immunization Technical Advisory Group: a valuable asset for the national immunization program and the immunization agenda in the EMRO region.

Authors:  Imane Jroundi; Mohammed Benazzouz; Abdel Hakim Yahyane; Moulay Tahar Alaoui; Nathalie El Omeiri
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.